Correlation Between Nrgene Technologies and Clal Biotechnology
Can any of the company-specific risk be diversified away by investing in both Nrgene Technologies and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nrgene Technologies and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nrgene Technologies and Clal Biotechnology Industries, you can compare the effects of market volatilities on Nrgene Technologies and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nrgene Technologies with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nrgene Technologies and Clal Biotechnology.
Diversification Opportunities for Nrgene Technologies and Clal Biotechnology
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Nrgene and Clal is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Nrgene Technologies and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Nrgene Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nrgene Technologies are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Nrgene Technologies i.e., Nrgene Technologies and Clal Biotechnology go up and down completely randomly.
Pair Corralation between Nrgene Technologies and Clal Biotechnology
Assuming the 90 days trading horizon Nrgene Technologies is expected to generate 2.33 times more return on investment than Clal Biotechnology. However, Nrgene Technologies is 2.33 times more volatile than Clal Biotechnology Industries. It trades about 0.32 of its potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.05 per unit of risk. If you would invest 29,100 in Nrgene Technologies on September 1, 2024 and sell it today you would earn a total of 7,440 from holding Nrgene Technologies or generate 25.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 94.44% |
| Values | Daily Returns |
Nrgene Technologies vs. Clal Biotechnology Industries
Performance |
| Timeline |
| Nrgene Technologies |
| Clal Biotechnology |
Nrgene Technologies and Clal Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nrgene Technologies and Clal Biotechnology
The main advantage of trading using opposite Nrgene Technologies and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nrgene Technologies position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.The idea behind Nrgene Technologies and Clal Biotechnology Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Clal Biotechnology vs. Bezeq Israeli Telecommunication | Clal Biotechnology vs. Brainsway | Clal Biotechnology vs. Mivne Real Estate | Clal Biotechnology vs. Photomyne |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |